ストックスクリーナーアプリを入手
3.0999
27.45%
-1.1501
前日終値:
$4.25
開ける：
$3.255
24時間の取引高:
26.75M
Relative Volume:
5.26
時価総額：
$697.85M
収益：
-
当期純損益:
$-283.26M
株価収益率:
-2.1088
EPS:
-1.47
ネットキャッシュフロー:
$-273.61M
1週間 パフォーマンス:
-24.05%
1か月 パフォーマンス:
-0.53%
6か月 パフォーマンス:
+3.13%
1年 パフォーマンス:
-34.67%
1日の値動き範囲:
$2.88
$3.32
1週間の範囲:
$2.88
$4.365
52週間の値動き範囲:
$1.26
$7.30
Sana Biotechnology Inc Stock (SANA) Company Profile
名前
Sana Biotechnology Inc
セクター
電話
(206) 701-7914
住所
188 EAST BLAINE STREET, SUITE 400, SEATTLE
SANA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
3.095 | 960.87M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
377.71 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.66 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.63 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
668.20 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
296.01 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-03-18 | アップグレード | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | 開始されました | Jefferies | Buy |
| 2025-01-08 | アップグレード | TD Cowen | Hold → Buy |
| 2024-11-05 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 開始されました | Rodman & Renshaw | Buy |
| 2024-01-16 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-09-05 | 開始されました | Citigroup | Buy |
| 2023-08-14 | 開始されました | TD Cowen | Market Perform |
| 2023-05-02 | 開始されました | H.C. Wainwright | Neutral |
| 2021-03-01 | 開始されました | BofA Securities | Buy |
| 2021-03-01 | 開始されました | Goldman | Neutral |
| 2021-03-01 | 開始されました | JP Morgan | Neutral |
| 2021-03-01 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Sana Biotechnology Inc (SANA) 最新ニュース
Sana Biotechnology stock tumbles after pricing public offering By Investing.com - Investing.com Canada
Sana Biotechnology prices $75 million public offering at $3.35 per share - Investing.com Australia
Sana Biotechnology Announces Pricing of Public Offering - Benzinga
Sana Biotechnology Announces Pricing of Public Offering - GlobeNewswire
Sana Biotechnology launches $75 million public offering - Investing.com
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewswire
Sana Biotechnology shares rise 1.42% after-hours following positive study results on HIP-modified pancreatic islet cells. - AInvest
Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes - GlobeNewswire
Revolutionary Type 1 Diabetes Breakthrough: Patient Produces Insulin After 35 Years Through Novel Cell Transplant - Stock Titan
What analysts say about Sana Biotechnology Inc. stockHigh-yield capital appreciation - Jammu Links News
What catalysts could drive Sana Biotechnology Inc. stock higher in 2025Achieve fast wealth growth with smart picks - Jammu Links News
When is Sana Biotechnology Inc. stock expected to show significant growthGet exclusive market insights for better trading - Jammu Links News
Is it the right time to buy Sana Biotechnology Inc. stockAmplify your gains with low-risk picks - Jammu Links News
What is the dividend policy of Sana Biotechnology Inc. stockUnprecedented profits - Jammu Links News
What are the technical indicators suggesting about Sana Biotechnology Inc.Maximize gains with data-driven trading alerts - Jammu Links News
Sana Biotechnology (SANA) Rated ‘Market Perform’ on Diabetes Program Prospects - MSN
Sana Biotechnology Inc. Stock Analysis and ForecastAchieve consistent profits with expert advice - Jammu Links News
What is Sana Biotechnology Inc. company’s growth strategyMaximize gains with data-driven trading alerts - Jammu Links News
Citi Remains Bullish on Sana Biotechnology (SANA) - MSN
Drawdown in Sana Biotechnology Inc. May Be Nearing EndHigh Growth Low Risk Stock Selection Gets Analyst Nod - metal.it
Citi Maintains Buy Rating on Sana Biotechnology with $15 Price Target - AInvest
Is Sana Biotechnology Inc. a growth stock or a value stockFree Stock Recommendation For Fast Growth - jammulinksnews.com
10 Penny Stocks That Will Skyrocket - Insider Monkey
14 Best Biotech Penny Stocks to Buy Right Now - Insider Monkey
Why Sana Biotechnology Inc. stock attracts strong analyst attentionEntry Plan for Oversold Reversal Stocks Released - beatles.ru
Published on: 2025-07-29 13:54:31 - metal.it
Trading Bots Trigger Alerts on Sana Biotechnology Inc. ActivityTrade Insight With Community Collaboration Supported - metal.it
How does Sana Biotechnology Inc. compare to its industry peersFree Advanced Stock Screener Access - jammulinksnews.com
How volatile is Sana Biotechnology Inc. stock compared to the marketDaily Trading Entry Points For Every Investor - jammulinksnews.com
Is Sana Biotechnology Inc. stock overvalued or undervaluedGet exclusive market insights for better trading - Jammu Links News
Should I hold or sell Sana Biotechnology Inc. stock in 2025Track top-performing stocks effortlessly - Jammu Links News
How Sana Biotechnology Inc. stock performs during market volatilityFree Membership Group - metal.it
Is Sana Biotechnology Inc. a good long term investmentSuperior capital gains - PrintWeekIndia
What drives Sana Biotechnology Inc. stock priceConsistently profitable trades - Autocar Professional
When is the best time to buy Sana Biotechnology Inc. stockFree Stock Market Forecast Reports - jammulinksnews.com
Sana Biotechnology Inc (SANA) 財務データ
収益
当期純利益
現金流量
EPS
Sana Biotechnology Inc (SANA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
| Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
| Wyrick Susan D. | See Remarks |
Mar 02 '25 |
Option Exercise |
0.00 |
1,525 |
0 |
155,471 |
0.14%
0.27%
大文字化:
|
ボリューム (24 時間):